Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies
G Raverot, E Jouanneau… - European journal of …, 2014 - academic.oup.com
Pituitary tumours, the most frequent intracranial tumour, are historically considered benign.
However, various pieces of clinical evidence and recent advances in pathological and …
However, various pieces of clinical evidence and recent advances in pathological and …
Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies.
G Raverot, E Jouanneau, J Trouillas - European Journal of …, 2014 - europepmc.org
Pituitary tumours, the most frequent intracranial tumour, are historically considered benign.
However, various pieces of clinical evidence and recent advances in pathological and …
However, various pieces of clinical evidence and recent advances in pathological and …
Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies
G Raverot, E Jouanneau… - European journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Pituitary tumours, the most frequent intracranial tumour, are historically considered benign.
However, various pieces of clinical evidence and recent advances in pathological and …
However, various pieces of clinical evidence and recent advances in pathological and …
MANAGEMENT OF ENDOCRINE DISEASE Clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic …
G Raverot, E Jouanneau, J Trouillas - European Journal of …, 2014 - hero.epa.gov
Pituitary tumours, the most frequent intracranial tumour, are historically considered benign.
However, various pieces of clinical evidence and recent advances in pathological and …
However, various pieces of clinical evidence and recent advances in pathological and …